On the recordJanuary 28, 2020
The Orphan Drug Exclusivity Act, introduced by Representative Madeline Dean, will close a loophole...
Source
congress.govThe Orphan Drug Exclusivity Act, introduced by Representative Madeline Dean, will close a loophole...
Eshoo mentions Dean's act to prevent misuse of orphan drug exclusivity.
Share
More from Anna Eshoo
I want to ask you if you will consider STAs and if you will commit to providing the public transparency that is really due because this is a huge issue?
I find it hypocritical when I hear time and time and time again that plans are often blocked by PBMs from offering the lowest-priced generic.
I think that, you know, to a person--well, maybe not to a--well, just--I am getting myself in a little trouble here.
The next reauthorization must not repeat the failures of the 2018 law and should address its deficiencies.